TELO: Multiplikator Forward P/S Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals (TELO) - logo korporat

The bet on radical longevity through Telomir Pharmaceuticals (TELO) R&D is confirmed by the dynamics of the expected P/S valuation, where the value expresses the state of the metric. Telomir Pharmaceuticals (TELO) focuses on treating anemia and pulmonary fibrosis while penetrating the anti-aging market. Since the business relies on external financing without current sales, this chart demonstrates speculative demand for future technological breakthroughs.

TELO Telomir Pharmaceuticals, Inc.: Rasio rega marang prakiraan pendapatan ing interval 04.07.2022 - 16.11.2026

Ringkesan rincian data analitis Telomir Pharmaceuticals (TELO)

Analisis komprehensif perusahaan:TELO (Telomir Pharma)
Produk asli Telomir Pharmaceuticals Corp

Telomir Pharmaceuticals (TELO) laboratory diversification minimizes logistical risks in drug development, ensuring a stable stream of future revenues. This forward price-to-sales ratio compares the current market value of the business with expected sales volumes, allowing investors to assess the asset's overvaluation and the probability of a correction should actual performance deviate from calculated models.

Pesaing wigati

Multiplikator Forward P/S HLN (Haleon PLC)|Multiplikator Forward P/S Kenvue Corp KVUE|Verona Pharma PLC - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep jyongbio.com|LGND: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan AMRX|Rasio rega marang prakiraan pendapatan Perrigo Company|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alvotech ALVO|Multiplikator Forward P/S LQDA|GLPG: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S ANIP (ANI Pharmaceuticals, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake MannKind Corp (MNKD)|AMPH: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan TBPH|AQST (Aquestive Corp) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan scPharmaceuticals Inc. (SCPH)|Multiplikator forward rega marang pendapatan TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan SXT Pharmaceuticals SXTC|Rega forward marang dodolan EPRX|BHST - Rasio rega marang prakiraan pendapatan|eXoZymes (EXOZ) - Multiplikator forward rega marang pendapatan|ORMP: Multiplikator Forward P/S|ENTX: Rasio rega marang pendapatan sing dikarepake|HYFT (ipatherapeutics.com) - Multiplikator Forward P/S|Multiplikator Forward P/S ABVC BioPharma|Rasio rega marang prakiraan pendapatan Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Rega forward marang dodolan|Multiplikator Forward P/S FGEN (fibrogen.com)|RANI - Multiplikator forward rega marang pendapatan|SNYR - Rasio rega marang prakiraan pendapatan|rallybio.com - Rasio rega marang pendapatan sing dikarepake|LEXX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Pulmatrix Inc|PTHL (Pheton Holdings) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aptorum Group Limited APM|Rasio rega marang prakiraan pendapatan Lyra Therapeutics (LYRA)|Multiplikator forward rega marang pendapatan Impact BioMedical Inc IBO|Rasio rega marang prakiraan pendapatan tnfpharma.com TNFA|Rega forward marang dodolan YCBD|PainReform Ltd - Multiplikator Forward P/S|Altamira Therapeutics Ltd (CYTO) - Multiplikator forward rega marang pendapatan|lipella.com (LIPO) - Rasio rega marang prakiraan pendapatan|OptiNose (OPTN) - Multiplikator Forward P/S|PIRS (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|PROC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Petros Pharmaceuticals, Inc. (PTPI)|Multiplikator Forward P/S Qilian International Corp (QLI)|ACELYRIN, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S tffpharma.com TFFP